Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers : a combined analysis of four randomized studies

スポンサーリンク

概要

• 論文の詳細を見る
• 1999-09-01

著者

• Steed David

  Department Of Surgery University Of Pittsburgh Medical Center

• Wieman Jeffery

  Department Of Surgery University Of Louisville

• SMIELL Janice

  The R. W. Johnson Pharmaceutical Research Institute

• PERRY Barbara

  The R. W. Johnson Pharmaceutical Research Institute

• SAMPSON Allan

  Department of Statistics, University of Pittsburgh

• SCHWAB Barry

  The R. W. Johnson Pharmaceutical Research Institute

• Sampson Allan

  Department Of Statistics University Of Pittsburgh

関連論文

• Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers : an open-label clinical evaluation of efficacy
• Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers : a combined analysis of four randomized studies
• Becaplermin gelin the treatment of pressure ulcers : a phase II randomized, double-blind, placebo-controlled study
• Guidelines to aid healing of acute wounds by decreasing impediments of healing

スポンサーリンク